Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting

Rhea-AI Summary

Spectral AI (NASDAQ: MDAI) showcased its DeepView® System at the American Burn Association annual meeting in Phoenix, Arizona. The event, attended by over 2,200 burn care professionals, highlighted significant achievements in burn wound assessment technology.

Key findings presented by Leslie Tan of Newcastle Burns Centre revealed the DeepView System's impressive 95% accuracy rate in predicting burn wound healing potential within 21 days. The technology received additional recognition when Zeeshan Sheikh of Wythenshawe Hospital won Best in Category for his presentation on patient experience with AI-Enhanced Multispectral Imaging.

The DeepView System, which combines multi-spectral imaging with AI algorithms, is currently operational in several NHS hospitals in the United Kingdom. Newcastle Burn Centre, treating approximately 500 burn patients annually, became the first institution globally to conduct an independent evaluation of this technology.

Positive

• DeepView System demonstrates over 95% accuracy in predicting burn wound healing potential within 21 days
• System already deployed in multiple NHS hospitals in UK, showing market penetration
• First independent product evaluation completed at Newcastle Burn Centre, a major facility treating 500 burn cases annually
• Strong clinical validation through successful presentations and recognition at major industry conference

Negative

• Product still in pre-commercial phase, awaiting full launch
• Limited geographical presence, currently only in UK hospitals

Insights

Medical Technology Analyst

DeepView® System shows 95% accuracy for burn healing prediction with UK hospital adoption and clinical recognition, validating Spectral AI's core technology.

The clinical data presented at the American Burn Association meeting offers compelling validation for Spectral AI's DeepView® System. UK clinician Leslie Tan reported over 95% accuracy in predicting burn wound healing potential by 21 days, describing it as "one of the highest I've seen amongst the machines I've evaluated over the last few years." This level of accuracy is particularly significant in burn care, where precise assessment directly impacts treatment decisions.

The system has achieved practical implementation in multiple NHS hospitals across the United Kingdom, with Newcastle Burn Centre (treating approximately 500 burn patients annually) completing the first independent product evaluation globally. This real-world clinical integration demonstrates practical utility beyond theoretical applications.

The technology's recognition at the conference, including a "Best in Category" award for a poster on patient experience, signals growing clinical acceptance. The multi-spectral imaging approach combined with AI algorithms addresses a persistent challenge in burn assessment - accurate healing prediction - which traditionally relies on subjective visual examination. This objective measurement tool represents a meaningful advancement in burn care technology and suggests strong clinical foundation for Spectral AI's referenced "future commercial launch."

Healthcare Investment Analyst

Spectral AI's DeepView shows strong clinical validation with 95% accuracy and UK hospital adoption, building foundation for commercial success.

This clinical validation represents a significant milestone in Spectral AI's commercial development pathway. The 95% accuracy rate in predicting burn wound healing directly addresses a critical unmet need in burn assessment, potentially creating value through both improved patient outcomes and healthcare cost efficiency via more appropriate treatment planning.

The current implementation across multiple NHS hospitals provides real-world validation and establishes credibility within a major healthcare system. This UK presence creates an important reference market and suggests the technology has passed initial clinical utility hurdles.

The recognition at the American Burn Association meeting enhances market visibility among key stakeholders. The engagement strategies mentioned - including "dynamic presentations," "breakfast symposia with key clinical investigators," and "multiple interactions" - demonstrate effective clinical community outreach essential for medical technology adoption.

While the press release references a "future commercial launch," it doesn't specify regulatory status, approval timelines, or commercialization strategies beyond the UK. The current hospital implementations likely represent evaluation agreements rather than full commercial rollout. Nevertheless, this growing clinical validation substantially de-risks the technology development pathway and positions the company for potential commercial success.

DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView^® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced its successful participation at the American Burn Association annual meeting, dedicated to burn awareness and prevention. The event, held from April 7^th - 11^th in Phoenix, Arizona, brought together over 2,200 burn care professionals worldwide.

This year’s meeting showcased the latest advancements in burn care, fostered interdisciplinary collaboration, and celebrated the burn care community’s dedication. Burn and Plastics Senior Registar Leslie Tan of Newcastle Burns Centre, who has been using the DeepView System, presented his findings of a multi-center UK trial of artificial intelligence enhanced multispectral imaging for burn wound assessments. Mr. Tan stated: “From our initial studies, the DeepView^® technology is showing over 95% overall accuracy when predicting healing potential in a burn wound by 21 days. [This accuracy] is one of the highest I’ve seen amongst the machines I’ve evaluated over the last few years.”

Working with the DeepView System, Zeeshan Sheikh, of Wythenshawe Hospital in the UK, won Best in Category with his poster presentation on “Patient experience of using Artificial Intelligence-Enhanced Multispectral Imaging: A regional Burns Center Review”. The Company also debuted the DeepView System devices at the conference to a welcome reception. Spectral AI engaged with clinicians through dynamic presentations of the DeepView System, breakfast symposia with key clinical investigators and multiple other interactions with the burn community fostering excitement about the product and future commercial launch. The DeepView System device is being used in several NHS hospitals in the United Kingdom and last year, experts at the Newcastle Burn Centre, who see on average 500 people with burn wounds a year, became the first institution in the world to carry out an independent product evaluation of our technology.

About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown^®” with its DeepView^® System. The DeepView^® System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView^® System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView^® System, visit www.spectral-ai.com.

Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements. 

Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. 

For Media and Investor Relations, please contact:  

David Kugelman  
Atlanta Capital Partners LLC  
(866) 692-6847 Toll Free - U.S. & Canada  
(404) 281-8556 Mobile and WhatsApp  
Email: dk@atlcp.com

FAQ

What accuracy rate did DeepView System achieve in burn wound healing prediction according to the 2025 ABA meeting?

According to Leslie Tan from Newcastle Burns Centre, the DeepView System demonstrated over 95% overall accuracy in predicting burn wound healing potential within 21 days, reported as one of the highest accuracy rates among evaluated machines.

Which UK hospitals are currently using Spectral AI's (MDAI) DeepView System for burn assessment?

The DeepView System is being used in several NHS hospitals in the United Kingdom, with Newcastle Burn Centre being the first institution worldwide to conduct an independent product evaluation of the technology.

How many burn care professionals attended the 2025 American Burn Association meeting where MDAI presented?

Over 2,200 burn care professionals from around the world attended the American Burn Association annual meeting held from April 7th - 11th, 2025, in Phoenix, Arizona.

What recognition did DeepView System receive at the 2025 ABA conference?

At the 2025 ABA conference, Zeeshan Sheikh from Wythenshawe Hospital won Best in Category for his poster presentation on patient experience using DeepView's AI-Enhanced Multispectral Imaging technology.

How many burn patients does Newcastle Burn Centre treat annually using MDAI's DeepView System?

Newcastle Burn Centre, which was the first to evaluate DeepView System, treats an average of 500 people with burn wounds annually.